Marie Kersten


Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output


Phase I dose-escalation study of brentuximab-vedotin combined with dexamethasone, high-dose cytarabine and cisplatin, as salvage treatment in relapsed/refractory classical hodgkin lymphoma: The HOVON/LLPC transplant brave study

Hagenbeek, A., Mooij, H., Zijlstra, J., Lugtenburg, P., van Imhoff, G., Nijland, M., Tonino, S., Hutchings, M., Spiering, M., Liu, R., van Tinteren, H. & Kersten, M. J., 31 Mar 2019, In : Haematologica. 104, 4, p. e151-e153

Research output: Contribution to journalLetterAcademicpeer-review

Open Access